| Product Code: ETC7915924 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Molecular Point of Care Testing (using NAAT) Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Molecular Point of Care Testing (using NAAT) Market - Industry Life Cycle |
3.4 Latvia Molecular Point of Care Testing (using NAAT) Market - Porter's Five Forces |
3.5 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Latvia Molecular Point of Care Testing (using NAAT) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Latvia |
4.2.2 Growing demand for rapid and accurate diagnostic solutions |
4.2.3 Technological advancements in molecular point of care testing (using NAAT) |
4.3 Market Restraints |
4.3.1 High cost associated with molecular point of care testing technology |
4.3.2 Limited awareness among healthcare professionals and patients about the benefits of NAAT testing |
4.3.3 Regulatory challenges and approval processes for new testing technologies |
5 Latvia Molecular Point of Care Testing (using NAAT) Market Trends |
6 Latvia Molecular Point of Care Testing (using NAAT) Market, By Types |
6.1 Latvia Molecular Point of Care Testing (using NAAT) Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Instruments, 2021- 2031F |
6.1.4 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.5 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Reagents, 2021- 2031F |
6.2 Latvia Molecular Point of Care Testing (using NAAT) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Respiratory Infections Testing, 2021- 2031F |
6.2.3 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Sexually Transmitted Infection (STI) Testing, 2021- 2031F |
6.2.4 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Gastrointestinal Tract Infections Testing, 2021- 2031F |
6.2.5 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Latvia Molecular Point of Care Testing (using NAAT) Market, By End users |
6.3.1 Overview and Analysis |
6.3.2 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3.3 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.5 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Ambulatory Centers, 2021- 2031F |
6.3.6 Latvia Molecular Point of Care Testing (using NAAT) Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Molecular Point of Care Testing (using NAAT) Market Import-Export Trade Statistics |
7.1 Latvia Molecular Point of Care Testing (using NAAT) Market Export to Major Countries |
7.2 Latvia Molecular Point of Care Testing (using NAAT) Market Imports from Major Countries |
8 Latvia Molecular Point of Care Testing (using NAAT) Market Key Performance Indicators |
8.1 Average turnaround time for NAAT test results |
8.2 Adoption rate of molecular point of care testing in healthcare facilities |
8.3 Rate of reimbursement for NAAT testing procedures |
8.4 Number of research studies and publications supporting the efficacy of NAAT testing |
8.5 Percentage of healthcare professionals trained in using NAAT testing technology |
9 Latvia Molecular Point of Care Testing (using NAAT) Market - Opportunity Assessment |
9.1 Latvia Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Latvia Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Latvia Molecular Point of Care Testing (using NAAT) Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Latvia Molecular Point of Care Testing (using NAAT) Market - Competitive Landscape |
10.1 Latvia Molecular Point of Care Testing (using NAAT) Market Revenue Share, By Companies, 2024 |
10.2 Latvia Molecular Point of Care Testing (using NAAT) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here